114 related articles for article (PubMed ID: 11071563)
1. Controlled vasoregulation of postischemic liver microcirculation--a therapeutic approach.
Spiegel HU; Uhlmann D; Uhlmann S
J Invest Surg; 2000; 13(5):273-8. PubMed ID: 11071563
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological regulation of postischemic sinusoidal diameters in rats--a new approach for reducing hepatic ischemia/reperfusion injury.
Uhlmann D; Uhlmann S; Löffler BM; Witzigmann H; Spiegel HU
Clin Hemorheol Microcirc; 2001; 24(4):233-46. PubMed ID: 11564912
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor blockade as a therapeutic strategy in ameliorating postischemic damage to the liver microcirculation.
Uhlmann D; Uhlmann S; Palmes D; Spiegel HU
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S351-3. PubMed ID: 11078418
[TBL] [Abstract][Full Text] [Related]
4. Important role for endothelins in acute hepatic ischemia/reperfusion injury.
Uhlmann D; Uhlmann S; Spiegel HU
J Invest Surg; 2001; 14(1):31-45. PubMed ID: 11297059
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury.
Scommotau S; Uhlmann D; Löffler BM; Breu V; Spiegel HU
Langenbecks Arch Surg; 1999 Feb; 384(1):65-70. PubMed ID: 10367633
[TBL] [Abstract][Full Text] [Related]
6. Effect of the endothelin receptor antagonist bosentan on postischemic oxygen supply of the liver.
Spiegel HU; Uhlmann D; Scommotau S; Giersch B; Sulkowski U
J Invest Surg; 1996; 9(6):439-45. PubMed ID: 8981217
[TBL] [Abstract][Full Text] [Related]
7. Improvement of postischemic hepatic microcirculation after endothelinA receptor blockade--endothelin antagonism influences platelet-endothelium interactions.
Uhlmann D; Glasser S; Gaebel G; Armann B; Ludwig S; Tannapfel A; Hauss J; Witzigmann H
J Gastrointest Surg; 2005 Feb; 9(2):187-97. PubMed ID: 15694814
[TBL] [Abstract][Full Text] [Related]
8. Effect of the endothelin receptor antagonist bosentan on postischemic liver microcirculation.
Spiegel HU; Scommotau S; Uhlmann D; Giersch B
Zentralbl Chir; 1996; 121(9):788-93. PubMed ID: 8921579
[TBL] [Abstract][Full Text] [Related]
9. Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury.
Uhlmann D; Scommotau S; Witzigmann H; Spiegel HU
Eur Surg Res; 1998; 30(3):175-84. PubMed ID: 9627214
[TBL] [Abstract][Full Text] [Related]
10. Effects of mixed ETA and ETB-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia.
Koeppel TA; Kraus T; Thies JC; Gebhard MM; Otto G; Post S
Dig Dis Sci; 1997 Jun; 42(6):1316-21. PubMed ID: 9201101
[TBL] [Abstract][Full Text] [Related]
11. Endothelin/nitric oxide balance influences hepatic ischemia-reperfusion injury.
Uhlmann D; Uhlmann S; Spiegel HU
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S212-4. PubMed ID: 11078380
[TBL] [Abstract][Full Text] [Related]
12. Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury.
Uhlmann D; Witzigmann H; Senninger N; Hauss J; Spiegel HU
Microvasc Res; 2001 Jul; 62(1):43-54. PubMed ID: 11421659
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-A receptor blockade improves postischemic hepatic microhemodynamics.
Uhlmann D; Glasser S; Lauer H; Ludwig S; Gaebel G; Serr F; Hauss J; Witzigmann H
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S103-4. PubMed ID: 15838253
[TBL] [Abstract][Full Text] [Related]
14. [Role of endothelin-nitrogen monoxide equilibrium in ischemia/reperfusion damage of the liver].
Uhlmann D; Scommotau S; Witzigmann H; Hauss J; Spiegel HU
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):329-33. PubMed ID: 14518270
[TBL] [Abstract][Full Text] [Related]
15. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.
Reichen J; Gerbes AL; Steiner MJ; Sägesser H; Clozel M
J Hepatol; 1998 Jun; 28(6):1020-30. PubMed ID: 9672179
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury.
Martin M; Mory C; Prescher A; Wittekind C; Fiedler M; Uhlmann D
J Gastrointest Surg; 2010 Mar; 14(3):511-9. PubMed ID: 19937475
[TBL] [Abstract][Full Text] [Related]
17. Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury.
Ricciardi R; Schaffer BK; Shah SA; Quarfordt SH; Banner BF; Wheeler SM; Donohue SE; Meyers WC; Chari RS
J Gastrointest Surg; 2001; 5(3):322-9. PubMed ID: 11360057
[TBL] [Abstract][Full Text] [Related]
18. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
19. Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury.
Vollmar B; Glasz J; Post S; Menger MD
J Surg Res; 1996 Jan; 60(1):49-54. PubMed ID: 8592431
[TBL] [Abstract][Full Text] [Related]
20. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor.
Mizunuma K; Ohdan H; Tashiro H; Fudaba Y; Ito H; Asahara T
Transplantation; 2003 Mar; 75(5):579-86. PubMed ID: 12640293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
